(Q48933168)

English

A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.

scientific article published in January 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

title

A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. (English)

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

0 references

1 reference

1 reference

Chouinard G

1

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

publication date

1 January 1990

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

published in

Acta psychiatrica Scandinavica. Supplementum

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

volume

358

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

page(s)

111-119

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

Identifiers

PubMed ID

1978469

1 reference

stated in

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/1978469

(Q48933168)

A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)